Jan 26 (Reuters) - The U.S. Food and Drug Administration
said on Thursday that  AstraZeneca's COVID-19 antibody
cocktail Evusheld is not currently authorized for use in the
United States until further notice by the agency.
(Reporting by Bhanvi Satija in Bengaluru)